MeiHua Holdings Group Co., Ltd. manufactures various pharmaceuticals. The Company manufactures monosodium glutamate, amino acids, L-Threonine L-Glutamine  L-Proline  and Natamycin.

Report for Q3 2025

Announcement on Operation Data for the First Three Quarters of 2025

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Meihua Holdings Group Co A (600873 CH)

Report for Q3 2025

Announcement on Operation Data for the First Three Quarters of 2025

Announcement on Progress in Cross-Border Acquisition Business and Assets

Announcement on Implementation Result of Shares Repurchase and Share Changes

Announcement on Progress in Repurchasing Shares through Call Auction

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)